Pfizer expects higher COVID-19 vaccine prices and annual boosters, says CFO. And that means big sales in the long run
Casa Blanca announces an agreement between Johnson & Johnson and its competitor Merck to manufacture the vaccine of a dose against COVID-19
The OMS supports the initiative to suspend the patents in the manufacture of the vacancies against the COVID-19